Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2022

Open Access 01-12-2022 | Cardiomyopathy | Research article

Left atrial dysfunction may precede left atrial enlargement and abnormal left ventricular longitudinal function: a cardiac MR feature tracking study

Authors: Di Zhou, Wenjing Yang, Yingxia Yang, Gang Yin, Shuang Li, Baiyan Zhuang, Jing Xu, Jian He, Weichun Wu, Yong Jiang, Xiaoxin Sun, Yining Wang, Arlene Sirajuddin, Shihua Zhao, Minjie Lu

Published in: BMC Cardiovascular Disorders | Issue 1/2022

Login to get access

Abstract

Background

The role of the dysfunction of left atrium in the occurrence and development of cardiovascular disease has been gradually recognized. We aim to compare the impact on left atrial (LA) function between patients with hypertrophic cardiomyopathy (HCM) and hypertension (HTN) without LA enlargement using cardiovascular magnetic resonance feature tracking (CMR-FT), and if possible, explore the capability of LA function for providing clinical implication and predicting clinical adverse events in the early stage of cardiovascular disease.

Methods

Consecutive 60 HCM patients and 60 HTN patients with normal LA size among 1413 patients who underwent CMR were retrospectively analyzed as well as 60 controls. Left atrial and ventricular functions were quantified by volumetric and CMR-FT derived strain analysis from long and short left ventricular view cines. The primary endpoint was a composite of all-cause death, stroke, new-onset or worsening heart failure to hospitalization, and paroxysmal or persistent atrial fibrillation.

Results

Compared to the controls, both HTN and HCM participants had impaired LA reservoir function (εs) and conduit function (εe) with the different stage of LA booster pump dysfunction (εa). LA strain was more sensitive than LV longitudinal strain (GLS) for evaluate primary endpoint (εs: 33.9% ± 7.5 vs. 41.2% ± 14.3, p = 0.02; εe: 13.6% ± 6.2 vs. 17.4% ± 10.4, p = 0.03; εa: 20.2% ± 6.0 vs. 23.7% ± 8.8, p = 0.07; GLS: -19.4% ± 6.4 vs. -20.0% ± 6.8, p = 0.70, respectively). After a mean follow-up of 6.8 years, 23 patients reached primary endpoint. Cox regression analyses indicated impaired LA reservoir and booster pump strain were associated with clinical outcomes in patients at the early stage of HTN and HCM (p < 0.05).

Conclusions

CMR-FT-derived strain is a potential and robust tool in demonstrating impaired LA mechanics, quantifying LA dynamics and underlining the impacts on LA-LV coupling in patients with HTN and HCM without LA enlargement. The corresponding LA dysfunction is a promising metric to assess clinical implication and predict prognosis at the early stage, superior to GLS.
Literature
1.
go back to reference Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16:233–70.PubMedCrossRef Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16:233–70.PubMedCrossRef
2.
go back to reference Guttmann OP, Rahman MS, O’Mahony C, et al. Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review. Heart (British Cardiac Society). 2014;100:465–72. Guttmann OP, Rahman MS, O’Mahony C, et al. Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review. Heart (British Cardiac Society). 2014;100:465–72.
3.
go back to reference Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:2733–79.CrossRef Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:2733–79.CrossRef
4.
go back to reference Demir M, Aktaş İ, Yıldırım A. Left atrial mechanical function and stiffness in patients with nondipper hypertension: a speckle tracking study. Clin Exp Hypertens. 2017;39:319–24.PubMedCrossRef Demir M, Aktaş İ, Yıldırım A. Left atrial mechanical function and stiffness in patients with nondipper hypertension: a speckle tracking study. Clin Exp Hypertens. 2017;39:319–24.PubMedCrossRef
5.
go back to reference Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–104.PubMedCrossRef Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–104.PubMedCrossRef
6.
go back to reference Yang Y, Yin G, Jiang Y, et al. Quantification of left atrial function in patients with non-obstructive hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking imaging: a feasibility and reproducibility study. J Cardiovasc Magn Reson. 2020;22:1.PubMedPubMedCentralCrossRef Yang Y, Yin G, Jiang Y, et al. Quantification of left atrial function in patients with non-obstructive hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking imaging: a feasibility and reproducibility study. J Cardiovasc Magn Reson. 2020;22:1.PubMedPubMedCentralCrossRef
7.
go back to reference Debonnaire P, Joyce E, Hiemstra Y, et al. Left atrial size and function in hypertrophic cardiomyopathy patients and risk of new-onset atrial fibrillation. Circ Arrhythm Electrophysiol. 2017;10:e004052.PubMedCrossRef Debonnaire P, Joyce E, Hiemstra Y, et al. Left atrial size and function in hypertrophic cardiomyopathy patients and risk of new-onset atrial fibrillation. Circ Arrhythm Electrophysiol. 2017;10:e004052.PubMedCrossRef
8.
go back to reference Sarvari SI, Haugaa KH, Stokke TM, et al. Strain echocardiographic assessment of left atrial function predicts recurrence of atrial fibrillation. Eur Heart J Cardiovasc Imaging. 2016;17:660–7.PubMedCrossRef Sarvari SI, Haugaa KH, Stokke TM, et al. Strain echocardiographic assessment of left atrial function predicts recurrence of atrial fibrillation. Eur Heart J Cardiovasc Imaging. 2016;17:660–7.PubMedCrossRef
9.
go back to reference Cameli M, Lisi M, Focardi M, et al. Left atrial deformation analysis by speckle tracking echocardiography for prediction of cardiovascular outcomes. Am J Cardiol. 2012;110:264–9.PubMedCrossRef Cameli M, Lisi M, Focardi M, et al. Left atrial deformation analysis by speckle tracking echocardiography for prediction of cardiovascular outcomes. Am J Cardiol. 2012;110:264–9.PubMedCrossRef
10.
go back to reference Iio C, Inoue K, Nishimura K, et al. Characteristics of left atrial deformation parameters and their prognostic impact in patients with pathological left ventricular hypertrophy: analysis by speckle tracking echocardiography. Echocardiography. 2015;32:1821–30.PubMedCrossRef Iio C, Inoue K, Nishimura K, et al. Characteristics of left atrial deformation parameters and their prognostic impact in patients with pathological left ventricular hypertrophy: analysis by speckle tracking echocardiography. Echocardiography. 2015;32:1821–30.PubMedCrossRef
11.
go back to reference de Simone G, Pasanisi F, Contaldo F. Link of nonhemodynamic factors to hemodynamic determinants of left ventricular hypertrophy. Hypertension. 2001;38:13–8.PubMedCrossRef de Simone G, Pasanisi F, Contaldo F. Link of nonhemodynamic factors to hemodynamic determinants of left ventricular hypertrophy. Hypertension. 2001;38:13–8.PubMedCrossRef
12.
go back to reference Margulescu AD, Rees E, Coulson RM, et al. Do left atrial strain and strain rate reflect intrinsic atrial function, or are they determined by left ventricular function? Kardiol Pol. 2015;73:539–48.PubMedCrossRef Margulescu AD, Rees E, Coulson RM, et al. Do left atrial strain and strain rate reflect intrinsic atrial function, or are they determined by left ventricular function? Kardiol Pol. 2015;73:539–48.PubMedCrossRef
14.
go back to reference Zareian M, Ciuffo L, Habibi M, et al. Left atrial structure and functional quantitation using cardiovascular magnetic resonance and multimodality tissue tracking: validation and reproducibility assessment. J Cardiovasc Magn Reson. 2015;17:52–52.PubMedPubMedCentralCrossRef Zareian M, Ciuffo L, Habibi M, et al. Left atrial structure and functional quantitation using cardiovascular magnetic resonance and multimodality tissue tracking: validation and reproducibility assessment. J Cardiovasc Magn Reson. 2015;17:52–52.PubMedPubMedCentralCrossRef
15.
go back to reference Domsik P, Kalapos A, Chadaide S, et al. Three-dimensional speckle tracking echocardiography allows detailed evaluation of left atrial function in hypertrophic cardiomyopathy–insights from the MAGYAR-Path Study. Echocardiography (Mount Kisco, NY). 2014;31:1245–52.CrossRef Domsik P, Kalapos A, Chadaide S, et al. Three-dimensional speckle tracking echocardiography allows detailed evaluation of left atrial function in hypertrophic cardiomyopathy–insights from the MAGYAR-Path Study. Echocardiography (Mount Kisco, NY). 2014;31:1245–52.CrossRef
16.
go back to reference Leng S, Tan R-S, Zhao X, et al. Validation of a rapid semi-automated method to assess left atrial longitudinal phasic strains on cine cardiovascular magnetic resonance imaging. J Cardiovasc Magn Reson. 2018;20:71–71.PubMedPubMedCentralCrossRef Leng S, Tan R-S, Zhao X, et al. Validation of a rapid semi-automated method to assess left atrial longitudinal phasic strains on cine cardiovascular magnetic resonance imaging. J Cardiovasc Magn Reson. 2018;20:71–71.PubMedPubMedCentralCrossRef
17.
go back to reference Williams LK, Chan RH, Carasso S, et al. Effect of left ventricular outflow tract obstruction on left atrial mechanics in hypertrophic cardiomyopathy. Biomed Res Int. 2015;2015:481245–481245.PubMedPubMedCentralCrossRef Williams LK, Chan RH, Carasso S, et al. Effect of left ventricular outflow tract obstruction on left atrial mechanics in hypertrophic cardiomyopathy. Biomed Res Int. 2015;2015:481245–481245.PubMedPubMedCentralCrossRef
18.
go back to reference Truong VT, Palmer C, Wolking S, et al. Normal left atrial strain and strain rate using cardiac magnetic resonance feature tracking in healthy volunteers. Eur Heart J Cardiovasc Imaging. 2019;jez157. Truong VT, Palmer C, Wolking S, et al. Normal left atrial strain and strain rate using cardiac magnetic resonance feature tracking in healthy volunteers. Eur Heart J Cardiovasc Imaging. 2019;jez157.
19.
go back to reference Kowallick JT, Kutty S, Edelmann F, et al. Quantification of left atrial strain and strain rate using Cardiovascular Magnetic Resonance myocardial feature tracking: a feasibility study. J Cardiovasc Magn Reson. 2014;16:60–60.PubMedPubMedCentralCrossRef Kowallick JT, Kutty S, Edelmann F, et al. Quantification of left atrial strain and strain rate using Cardiovascular Magnetic Resonance myocardial feature tracking: a feasibility study. J Cardiovasc Magn Reson. 2014;16:60–60.PubMedPubMedCentralCrossRef
20.
go back to reference Gastl M, Gotschy A, Polacin M, et al. Determinants of myocardial function characterized by CMR-derived strain parameters in left ventricular non-compaction cardiomyopathy. Sci Rep. 2019;9:15882.PubMedPubMedCentralCrossRef Gastl M, Gotschy A, Polacin M, et al. Determinants of myocardial function characterized by CMR-derived strain parameters in left ventricular non-compaction cardiomyopathy. Sci Rep. 2019;9:15882.PubMedPubMedCentralCrossRef
21.
go back to reference Vasquez N, Ostrander BT, Lu D-Y, et al. Low left atrial strain is associated with adverse outcomes in hypertrophic cardiomyopathy patients. J Am Soc Echocardiogr. 2019;32:593-603.e1.PubMedCrossRef Vasquez N, Ostrander BT, Lu D-Y, et al. Low left atrial strain is associated with adverse outcomes in hypertrophic cardiomyopathy patients. J Am Soc Echocardiogr. 2019;32:593-603.e1.PubMedCrossRef
22.
go back to reference Chirinos JA, Sardana M, Ansari B, et al. Left atrial phasic function by cardiac magnetic resonance feature tracking is a strong predictor of incident cardiovascular events. Circ Cardiovasc Imaging. 2018;11:e007512–e007512.PubMedPubMedCentralCrossRef Chirinos JA, Sardana M, Ansari B, et al. Left atrial phasic function by cardiac magnetic resonance feature tracking is a strong predictor of incident cardiovascular events. Circ Cardiovasc Imaging. 2018;11:e007512–e007512.PubMedPubMedCentralCrossRef
23.
go back to reference Kawel-Boehm N, Kronmal R, Eng J, et al. Left ventricular mass at MRI and long-term risk of cardiovascular events: the multi-ethnic study of atherosclerosis (MESA). Radiology. 2019;293:107–14.PubMedCrossRef Kawel-Boehm N, Kronmal R, Eng J, et al. Left ventricular mass at MRI and long-term risk of cardiovascular events: the multi-ethnic study of atherosclerosis (MESA). Radiology. 2019;293:107–14.PubMedCrossRef
24.
go back to reference Kowallick JT, Morton G, Lamata P, et al. Quantification of atrial dynamics using cardiovascular magnetic resonance: inter-study reproducibility. J Cardiovasc Magn Reson. 2015;17:36–36.PubMedPubMedCentralCrossRef Kowallick JT, Morton G, Lamata P, et al. Quantification of atrial dynamics using cardiovascular magnetic resonance: inter-study reproducibility. J Cardiovasc Magn Reson. 2015;17:36–36.PubMedPubMedCentralCrossRef
26.
go back to reference Li L, Chen X, Yin G, et al. Early detection of left atrial dysfunction assessed by CMR feature tracking in hypertensive patients. Eur Radiol. 2020;30:702–11.PubMedCrossRef Li L, Chen X, Yin G, et al. Early detection of left atrial dysfunction assessed by CMR feature tracking in hypertensive patients. Eur Radiol. 2020;30:702–11.PubMedCrossRef
27.
go back to reference Hinojar R, Zamorano JL, Fernández-Méndez MA, et al. Prognostic value of left atrial function by cardiovascular magnetic resonance feature tracking in hypertrophic cardiomyopathy. Int J Cardiovasc Imaging. 2019;35:1055–65.PubMedCrossRef Hinojar R, Zamorano JL, Fernández-Méndez MA, et al. Prognostic value of left atrial function by cardiovascular magnetic resonance feature tracking in hypertrophic cardiomyopathy. Int J Cardiovasc Imaging. 2019;35:1055–65.PubMedCrossRef
28.
go back to reference Miyoshi H, Oishi Y, Mizuguchi Y, et al. Early predictors of alterations in left atrial structure and function related to left ventricular dysfunction in asymptomatic patients with hypertension. J Am Soc Hypertens. 2013;7:206–15.PubMedCrossRef Miyoshi H, Oishi Y, Mizuguchi Y, et al. Early predictors of alterations in left atrial structure and function related to left ventricular dysfunction in asymptomatic patients with hypertension. J Am Soc Hypertens. 2013;7:206–15.PubMedCrossRef
29.
go back to reference Thomas L, Marwick TH, Popescu BA, et al. Left atrial structure and function, and left ventricular diastolic dysfunction: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73:1961–77.PubMedCrossRef Thomas L, Marwick TH, Popescu BA, et al. Left atrial structure and function, and left ventricular diastolic dysfunction: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73:1961–77.PubMedCrossRef
30.
go back to reference Kowallick JT, Silva Vieira M, Kutty S, et al. Left atrial performance in the course of hypertrophic cardiomyopathy: relation to left ventricular hypertrophy and fibrosis. Invest Radiol. 2017;52:177–85.PubMedCrossRef Kowallick JT, Silva Vieira M, Kutty S, et al. Left atrial performance in the course of hypertrophic cardiomyopathy: relation to left ventricular hypertrophy and fibrosis. Invest Radiol. 2017;52:177–85.PubMedCrossRef
31.
go back to reference Olivotto I, Maron MS, Autore C, et al. Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008;52:559–66.PubMedCrossRef Olivotto I, Maron MS, Autore C, et al. Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008;52:559–66.PubMedCrossRef
32.
go back to reference Yang L, Qiu Q, Fang SH. Evaluation of left atrial function in hypertensive patients with and without left ventricular hypertrophy using velocity vector imaging. Int J Cardiovasc Imaging. 2014;30:1465–71.PubMedCrossRef Yang L, Qiu Q, Fang SH. Evaluation of left atrial function in hypertensive patients with and without left ventricular hypertrophy using velocity vector imaging. Int J Cardiovasc Imaging. 2014;30:1465–71.PubMedCrossRef
33.
go back to reference Semsarian C, Ingles J, Maron MS, et al. New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2015;65:1249–54.PubMedCrossRef Semsarian C, Ingles J, Maron MS, et al. New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2015;65:1249–54.PubMedCrossRef
34.
go back to reference Maron BJ, Gardin JM, Flack JM, et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation. 1995;92:785–9.PubMedCrossRef Maron BJ, Gardin JM, Flack JM, et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation. 1995;92:785–9.PubMedCrossRef
35.
go back to reference Keren A, Syrris P, McKenna WJ. Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression. Nat Clin Pract Cardiovasc Med. 2008;5:158–68.PubMedCrossRef Keren A, Syrris P, McKenna WJ. Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression. Nat Clin Pract Cardiovasc Med. 2008;5:158–68.PubMedCrossRef
36.
go back to reference Kim JB, Porreca GJ, Song L, et al. Polony multiplex analysis of gene expression (PMAGE) in mouse hypertrophic cardiomyopathy. Science. 2007;316:1481–4.PubMedCrossRef Kim JB, Porreca GJ, Song L, et al. Polony multiplex analysis of gene expression (PMAGE) in mouse hypertrophic cardiomyopathy. Science. 2007;316:1481–4.PubMedCrossRef
37.
go back to reference Xu J, Zhuang B, Sirajuddin A, et al. MRI T1 mapping in hypertrophic cardiomyopathy: evaluation in patients without late gadolinium enhancement and hemodynamic obstruction. Radiology. 2020;294:275–86.PubMedCrossRef Xu J, Zhuang B, Sirajuddin A, et al. MRI T1 mapping in hypertrophic cardiomyopathy: evaluation in patients without late gadolinium enhancement and hemodynamic obstruction. Radiology. 2020;294:275–86.PubMedCrossRef
38.
go back to reference Kim J, Yum B, Palumbo MC, et al. Left atrial strain impairment precedes geometric remodeling as a marker of post-myocardial infarction diastolic dysfunction. JACC Cardiovasc Imaging. 2020;13:2099–113.PubMedPubMedCentralCrossRef Kim J, Yum B, Palumbo MC, et al. Left atrial strain impairment precedes geometric remodeling as a marker of post-myocardial infarction diastolic dysfunction. JACC Cardiovasc Imaging. 2020;13:2099–113.PubMedPubMedCentralCrossRef
39.
go back to reference Melenovsky V, Hwang SJ, Redfield MM, et al. Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction. Circ Heart Fail. 2015;8:295–303.PubMedCrossRef Melenovsky V, Hwang SJ, Redfield MM, et al. Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction. Circ Heart Fail. 2015;8:295–303.PubMedCrossRef
40.
go back to reference Sanchis L, Gabrielli L, Andrea R, et al. Left atrial dysfunction relates to symptom onset in patients with heart failure and preserved left ventricular ejection fraction. Eur Heart J Cardiovasc Imaging. 2015;16:62–7.PubMedCrossRef Sanchis L, Gabrielli L, Andrea R, et al. Left atrial dysfunction relates to symptom onset in patients with heart failure and preserved left ventricular ejection fraction. Eur Heart J Cardiovasc Imaging. 2015;16:62–7.PubMedCrossRef
41.
go back to reference Leng S, Ge H, He J, et al. Long-term prognostic value of cardiac MRI left atrial strain in ST-segment elevation myocardial infarction. Radiology. 2020;296:299–309.PubMedCrossRef Leng S, Ge H, He J, et al. Long-term prognostic value of cardiac MRI left atrial strain in ST-segment elevation myocardial infarction. Radiology. 2020;296:299–309.PubMedCrossRef
42.
go back to reference Schuster A, Backhaus SJ, Stiermaier T, et al. Left atrial function with MRI enables prediction of cardiovascular events after myocardial infarction: insights from the AIDA STEMI and TATORT NSTEMI trials. Radiology. 2019;293:292–302.PubMedCrossRef Schuster A, Backhaus SJ, Stiermaier T, et al. Left atrial function with MRI enables prediction of cardiovascular events after myocardial infarction: insights from the AIDA STEMI and TATORT NSTEMI trials. Radiology. 2019;293:292–302.PubMedCrossRef
43.
go back to reference Negishi K, Negishi T, Zardkoohi O, et al. Left atrial booster pump function is an independent predictor of subsequent life-threatening ventricular arrhythmias in non-ischaemic cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2016;17:1153–60.PubMedCrossRef Negishi K, Negishi T, Zardkoohi O, et al. Left atrial booster pump function is an independent predictor of subsequent life-threatening ventricular arrhythmias in non-ischaemic cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2016;17:1153–60.PubMedCrossRef
44.
go back to reference Ersbøll M, Andersen MJ, Valeur N, et al. The prognostic value of left atrial peak reservoir strain in acute myocardial infarction is dependent on left ventricular longitudinal function and left atrial size. Circ Cardiovasc Imaging. 2013;6:26–33.PubMedCrossRef Ersbøll M, Andersen MJ, Valeur N, et al. The prognostic value of left atrial peak reservoir strain in acute myocardial infarction is dependent on left ventricular longitudinal function and left atrial size. Circ Cardiovasc Imaging. 2013;6:26–33.PubMedCrossRef
45.
go back to reference Schuster A, Hor KN, Kowallick JT, et al. Cardiovascular magnetic resonance myocardial feature tracking: concepts and clinical applications. Circ Cardiovasc Imaging. 2016;9:e004077.PubMedCrossRef Schuster A, Hor KN, Kowallick JT, et al. Cardiovascular magnetic resonance myocardial feature tracking: concepts and clinical applications. Circ Cardiovasc Imaging. 2016;9:e004077.PubMedCrossRef
Metadata
Title
Left atrial dysfunction may precede left atrial enlargement and abnormal left ventricular longitudinal function: a cardiac MR feature tracking study
Authors
Di Zhou
Wenjing Yang
Yingxia Yang
Gang Yin
Shuang Li
Baiyan Zhuang
Jing Xu
Jian He
Weichun Wu
Yong Jiang
Xiaoxin Sun
Yining Wang
Arlene Sirajuddin
Shihua Zhao
Minjie Lu
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2022
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-022-02532-w

Other articles of this Issue 1/2022

BMC Cardiovascular Disorders 1/2022 Go to the issue